Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
5.81
-0.34 (-5.53%)
At close: Jul 11, 2025, 4:00 PM
5.83
+0.02 (0.34%)
After-hours: Jul 11, 2025, 6:52 PM EDT

Candel Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
2913694352224-
Upgrade
Market Cap Growth
475.56%767.25%-17.80%-76.95%--
Upgrade
Enterprise Value
21036822-3137-
Upgrade
Last Close Price
5.818.681.471.797.82-
Upgrade
PS Ratio
---413.761794.84-
Upgrade
PB Ratio
3.835.563.341.083.50-
Upgrade
P/TBV Ratio
3.905.563.341.083.50-
Upgrade
EV/Sales Ratio
----1092.09-
Upgrade
Debt / Equity Ratio
0.150.201.790.480.010.04
Upgrade
Asset Turnover
---0.000.000.00
Upgrade
Quick Ratio
4.592.742.5012.4815.417.44
Upgrade
Current Ratio
4.642.772.5912.8115.847.46
Upgrade
Return on Equity (ROE)
-98.14%-139.56%-125.50%-33.61%-80.60%-53.16%
Upgrade
Return on Assets (ROA)
-32.31%-27.55%-39.95%-26.01%-25.22%-20.51%
Upgrade
Return on Capital (ROIC)
-36.46%-35.37%-44.80%-32.10%-35.28%-25.43%
Upgrade
Earnings Yield
-13.60%-14.97%-89.24%-36.34%-16.10%-
Upgrade
FCF Yield
-9.35%-7.33%-81.63%-63.26%-10.72%-
Upgrade
Buyback Yield / Dilution
-27.55%-9.47%-0.39%-52.72%-62.49%-0.70%
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q